Phase II Randomized Comparison of Topotecan Plus Cyclophosphamide Versus Topotecan Alone in Children With Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Study

PURPOSE: Single-agent topotecan (TOPO) and combination topotecan and cyclophosphamide (TOPO/CTX) were compared in a phase II randomized trial in relapsed/refractory neuroblastoma. Because responders often underwent further therapies, novel statistical methods were required to compare the long-term o...

詳細記述

保存先:
書誌詳細
主要な著者: London, Wendy B., Frantz, Christopher N., Campbell, Laura A., Seeger, Robert C., Brumback, Babette A., Cohn, Susan L., Matthay, Katherine K., Castleberry, Robert P., Diller, Lisa
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2010
主題:
Original Reports
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2940398/
https://ncbi.nlm.nih.gov/pubmed/20660830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.5016
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料